CTF1
Cardiotrophin-1
Also known as: CT-1, CT1, CTF1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16619
- Gene
- CTF1
- Ensembl
- ENSG00000150281
- Chromosome
- 16
- Canonical length
- 201 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a secreted cytokine that induces cardiac myocyte hypertrophy in vitro. It has been shown to bind and activate the ILST/gp130 receoptor. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Canonical amino-acid sequenceUniProt
201 residues, UniProt reviewed canonical sequence.
>Q16619|CTF1
1 MSRREGSLED PQTDSSVSLL PHLEAKIRQT HSLAHLLTKY AEQLLQEYVQ LQGDPFGLPS
61 FSPPRLPVAG LSAPAPSHAG LPVHERLRLD AAALAALPPL LDAVCRRQAE LNPRAPRLLR
121 RLEDAARQAR ALGAAVEALL AALGAANRGP RAEPPAATAS AASATGVFPA KVLGLRVCGL
181 YREWLSRTEG DLGQLLPGGS ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CTF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- ovary: 17 nTPM
- endometrium: 16 nTPM
- heart muscle: 15 nTPM
- blood vessel: 15 nTPM
- urinary bladder: 14 nTPM
- cervix: 14 nTPM
Single-cell type
- smooth muscle cells: 21 nCPM
- epididymal basal cells: 21 nCPM
- respiratory ciliated cells: 19 nCPM
- fallopian tube ciliated cells: 18 nCPM
- fallopian secretory cells: 18 nCPM
- alveolar cells type 1: 18 nCPM
Immune cell
- basophil: 0.6 nTPM
- neutrophil: 0.4 nTPM
- plasmacytoid DC: 0.3 nTPM
- MAIT T-cell: 0.2 nTPM
- myeloid DC: 0.2 nTPM
- naive B-cell: 0.2 nTPM
Brain region
- midbrain: 9.9 nTPM
- spinal cord: 9.2 nTPM
- medulla oblongata: 8.8 nTPM
- choroid plexus: 8.6 nTPM
- thalamus: 8 nTPM
- white matter: 7.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.74
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.81
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway via JAK-STAT
- cell-cell signaling
- muscle organ development
- nervous system development
- neuron development
- neuron differentiation
- positive regulation of cell population proliferation
- positive regulation of tyrosine phosphorylation of STAT protein
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CTF1 as an antibody target. Whether an autoantibody or antibody against CTF1 could matter depends on whether native CTF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CTF1 is annotated as secreted, so native CTF1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CTF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...